PMEF
AMGN icon

Point72 Middle East FZE’s Amgen AMGN Stock Holding History

Point72 Middle East FZE’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-31,082
Closed -$8.95M – 84
2023
Q4 		$8.95M Buy
+31,082
New +$8.47M 0.26% 75
2023
Q3 		– Sell
-24,805
Closed -$6.19M – 1423
2023
Q2 		$5.51M Buy
+24,805
New +$5.76M 0.15% 170
2023
Q1 		– Sell
-3,676
Closed -$902K – 1602
2022
Q4 		$965K Buy
+3,676
New +$985K 0.04% 521

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Middle East FZE's AMGN Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Amgen (AMGN) in Q1 2024, closing a stake of 31,082 shares — an estimated $8.95M sold.

Point72 Middle East FZE first reported a position in AMGN in Q4 2022 and held it in 3 quarters. The position peaked at $8.95M in Q4 2023. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 31,082 Amgen shares in Q1 2024, an estimated $8.95M.
  • Point72 Middle East FZE first reported a position in Amgen in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Amgen position peaked at $8.95M in Q4 2023.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.